Research Analysts Set Expectations for Exelixis Q1 Earnings
Exelixis, Inc. (NASDAQ:EXEL – Free Report) – Investment analysts at Leerink Partnrs raised their Q1 2025 EPS estimates for Exelixis in a report released on Monday, April 28th. Leerink Partnrs analyst A. Berens now expects that the biotechnology company will earn $0.37 per share for the quarter, up from their prior estimate of $0.36. The […]
Exelixis, Inc. (NASDAQ:EXEL – Free Report) – Investment analysts at Leerink Partnrs raised their Q1 2025 EPS estimates for Exelixis in a report released on Monday, April 28th. Leerink Partnrs analyst A. Berens now expects that the biotechnology company will earn $0.37 per share for the quarter, up from their prior estimate of $0.36. The […]
